Radium-223 (Ra-223\text{Ra-223}Ra-223) is a clinically approved radiopharmaceutical used in targeted cancer therapy to treat bone metastases. During its primary decay, a Radium-223 nucleus (88223Ra^{223}_{88}\text{Ra}88223Ra) transforms into a Radon-219 nucleus (86219Rn^{219}_{86}\text{Rn}86219Rn).
Which type of ionising radiation is emitted during this decay step?
alpha
beta-minus
beta-plus
gamma